Splenectomy combined with gastrectomy and immunotherapy for advanced gastric cancer.
We studied the effects of a splenectomy in combination with immunotherapy on the survival of patients who had undergone a total gastrectomy. It was found that a splenectomy was not effective against advanced gastric cancer at stage III, and that the spleen should be retained for immunotherapy. Splenectomy for gastric cancer at terminal stage IV, particularly in combination with immunotherapy, produced not only augmentation of cellular immunity, but also increased survival.
D005743:Gastrectomy; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D011183:Postoperative Complications; D013156:Splenectomy; D013274:Stomach Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*